SCM
Stonepine Capital Management Portfolio holdings
AUM
$102M
This Quarter Return
+1.16%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$167M
AUM Growth
+$167M
(-1.7%)
Cap. Flow
+$1.15M
Cap. Flow
% of AUM
0.69%
Top 10 Holdings %
Top 10 Hldgs %
73.09%
Holding
35
New
13
Increased
8
Reduced
5
Closed
8
Top Buys
| 1 |
Vanda Pharmaceuticals
VNDA
|
$8.89M |
| 2 |
BSTC
BioSpecifics Technologies Corp.
BSTC
|
$7.56M |
| 3 |
CareDx
CDNA
|
$6.75M |
| 4 |
Veracyte
VCYT
|
$5.91M |
| 5 |
ALIM
Alimera Sciences, Inc.
ALIM
|
$4.1M |
Top Sells
| 1 |
Pacira BioSciences
PCRX
|
$14.1M |
| 2 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$10.3M |
| 3 |
Enanta Pharmaceuticals
ENTA
|
$10.1M |
| 4 |
Vericel Corp
VCEL
|
$5.85M |
| 5 |
SCTL
Societal CDMO, Inc. Common Stock
SCTL
|
$3.75M |
Sector Composition
| 1 | Healthcare | 98.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRN
26
Amarin Corp
AMRN
$311M
| $70K | 0.04% |
+17,533
| New | +$70K |
|
|
CBMX
27
DELISTED
CombiMatrix Corporation
CBMX
| – | – |
-63,283
| Closed | -$475K |
|
|
AVDL
28
Avadel Pharmaceuticals
AVDL
$1.43B
| – | – |
-985,210
| Closed | -$10.3M |
|
|
29
Pacira BioSciences
PCRX
$1.2B
| – | – |
-375,200
| Closed | -$14.1M |
|
|
TRIB
30
Trinity Biotech
TRIB
$5.44M
| – | – |
-122,668
| Closed | -$688K |
|
|
31
Vericel Corp
VCEL
$1.83B
| – | – |
-975,711
| Closed | -$5.85M |
|
|
ICPT
32
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| – | – |
-18,600
| Closed | -$1.08M |
|
|
OXFD
33
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| – | – |
-162,286
| Closed | -$2.73M |
|
|
CASM
34
DELISTED
CAS Medical Systems, Inc.
CASM
| – | – |
-812,718
| Closed | -$748K |
|